FOXM1 in Cancer: Interactions and Vulnerabilities.
1Department of Medicine, University of Illinois at Chicago, Chicago, Illinois. agartel@uic.edu.
Cancer Research
|June 7, 2017
Summary
The transcription factor FOXM1, essential for normal cell growth, drives cancer progression when overexpressed. Its interactions with other proteins, like beta-catenin and SMAD3, are key to cancer development and potential drug targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- FOXM1 (Forkhead box protein M1) is a transcription factor crucial for normal cell proliferation.
- Overexpression of FOXM1 is frequently observed in various human cancers, contributing to major cancer hallmarks.
- FOXM1's oncogenic potential is linked to its ability to transactivate genes involved in cancer development.
Purpose of the Study:
- To review the critical protein-protein interactions of FOXM1 in cancer development.
- To identify FOXM1-mediated interactions as potential targets for novel anticancer therapeutics.
Main Methods:
- Literature review focusing on FOXM1's role in cancer.
- Analysis of FOXM1's interactions with proteins such as beta-catenin and SMAD3.
- Discussion of FOXM1's involvement in WNT and TGF-beta signaling pathways.
Main Results:
- FOXM1 interacts with beta-catenin to promote oncogenic WNT signaling.
- FOXM1 interacts with SMAD3, contributing to oncogenic TGF-beta signaling.
- These interactions highlight FOXM1's multifaceted role in driving cancer progression.
Conclusions:
- FOXM1 protein-protein interactions are critical for cancer development.
- Targeting these specific FOXM1 interactions offers promising avenues for developing new anticancer drugs.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
3.2K
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.9K
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
01:20Mismatch Repair
6.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.8K
02:43Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
01:06Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
02:30Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K